Literature DB >> 31060795

The current state of randomized clinical trial evidence for prostate brachytherapy.

Robert T Dess1, Payal D Soni2, William C Jackson3, Alejandro Berlin4, Brett W Cox5, Shruti Jolly3, Jason A Efstathiou6, Felix Y Feng7, Amar U Kishan8, Bradley J Stish9, Thomas M Pisansky9, Daniel E Spratt3.   

Abstract

Interstitial brachytherapy is one of several curative therapeutic options for the treatment of localized prostate cancer. In this review, we summarize all available randomized data to support the optimal use of prostate brachytherapy. Evidence from completed randomized controlled trials is the focus of this review with a presentation also of important ongoing trials. Gaps in knowledge are identified where future investigation may be fruitful with intent to inspire well-designed prospective studies with standardized treatment that focuses on improving oncological outcomes, reducing morbidity, or maintaining quality of life.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Brachytherapy; Combination therapy; HDR; LDR; Prostate cancer

Mesh:

Year:  2019        PMID: 31060795     DOI: 10.1016/j.urolonc.2019.04.009

Source DB:  PubMed          Journal:  Urol Oncol        ISSN: 1078-1439            Impact factor:   3.498


  4 in total

Review 1.  Financial toxicity associated with treatment of localized prostate cancer.

Authors:  Brandon S Imber; Melissa Varghese; Behfar Ehdaie; Daniel Gorovets
Journal:  Nat Rev Urol       Date:  2019-12-02       Impact factor: 14.432

Review 2.  Light-Induced Therapies for Prostate Cancer Treatment.

Authors:  Claudia Ferroni; Alberto Del Rio; Cecilia Martini; Elisabetta Manoni; Greta Varchi
Journal:  Front Chem       Date:  2019-10-29       Impact factor: 5.221

3.  High-dose-rate brachytherapy with external beam radiotherapy versus low-dose-rate brachytherapy with or without external beam radiotherapy for clinically localized prostate cancer.

Authors:  Hideya Yamazaki; Koji Masui; Gen Suzuki; Norihiro Aibe; Daisuke Shimizu; Takuya Kimoto; Kei Yamada; Akihisa Ueno; Toru Matsugasumi; Yasuhiro Yamada; Takumi Shiraishi; Atsuko Fujihara; Koji Okihara; Ken Yoshida; Satoaki Nakamura
Journal:  Sci Rep       Date:  2021-03-17       Impact factor: 4.379

4.  Addition of Androgen-Deprivation Therapy or Brachytherapy Boost to External Beam Radiotherapy for Localized Prostate Cancer: A Network Meta-Analysis of Randomized Trials.

Authors:  William C Jackson; Holly E Hartman; Robert T Dess; Sam R Birer; Payal D Soni; Jason W D Hearn; Zachary R Reichert; Amar U Kishan; Brandon A Mahal; Zachary S Zumsteg; Jason A Efstathiou; Samuel Kaffenberger; Todd M Morgan; Rohit Mehra; Timothy N Showalter; Daniel A Krauss; Paul L Nguyen; Matthew J Schipper; Felix Y Feng; Howard M Sandler; Peter J Hoskin; Mack Roach; Daniel E Spratt
Journal:  J Clin Oncol       Date:  2020-05-12       Impact factor: 44.544

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.